-
Mashup Score: 4
Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT has become the standard of care for many cancers such …
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
The use of artificial intelligence (AI) was a central theme at the 2024 ASCO Annual Meeting, including many tools, such as large language models, clinical trial matching, and image assessment, that are currently in use. However, the use of AI in oncology is in its infancy, and caution is needed given current data set limitations and the risk of amplifying existing disparities.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
The AI-Empowered Oncologist: A Look Back at ASCO24 Research to Improve Clinical Use https://t.co/OAaaBJTubU
-
-
Mashup Score: 26
Vivek Subbiah, MD, of Sarah Cannon Research Institute, explains what areas need to be addressed to make precision oncology more accessible.
Source: www.aacr.orgCategories: General Medicine News, Hem/OncsTweet-
🌟 Thrilled to Share My Latest Blog with @AACR ⭐️Creating a World Where Precision Oncology is a Reality for All ⭐️2024 was a terrific year for precision oncology & looking forward for more advances in 2025 @OncoAlert https://t.co/jTQgFF9XQT
-
-
Mashup Score: 2
Vivek Subbiah: Thrilled to Share My Latest Blog with AACR / AACR, AACR Blog, cancer, Cancer research, OncoDaily, Oncology, Precision Oncology, Research, Vivek
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Thrilled to Share My Latest Blog with @AACR - @VivekSubbiah https://t.co/Hkso9QN8bd #Cancer #PrecisionOncology #CancerCare…
-
-
Mashup Score: 4
OCE Insights is developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the FDA. In this installment, the authors discuss the past 5 years of Project Facilitate, an OCE in…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
Project Facilitate: 5 Years of Progress, Outreach, and Service - The ASCO Post https://t.co/f0asnGSUnY
-
-
Mashup Score: 8ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer - 6 day(s) ago
This interim update provides new recommendations for the following ESMO Clinical Practice Guideline (CPG): Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.1
Source: www.esmoopen.comCategories: General Medicine News, Hem/OncsTweet-
ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer - ESMO Open https://t.co/Ngv7KnBWxt
-
-
Mashup Score: 20
This nonrandomized controlled trial assesses the feasibility of using a circulating tumor DNA−guided adaptive de-escalation tyrosine kinase inhibitor strategy in patients with advanced non−small cell lung cancer to achieve complete remission after local consolidative therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
⭐️Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Lung Cancer @JAMAOnc - about time for LB-RECIST ? https://t.co/3oTJjjl7OD
-
-
Mashup Score: 4
OCE Insights is developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the FDA. In this installment, the authors discuss the past 5 years of Project Facilitate, an OCE in…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
Project Facilitate: 5 Years of Progress, Outreach, and Service - The ASCO Post https://t.co/f0asnGSUnY
-
-
Mashup Score: 7
Procarbazine induces a higher mutation burden and novel mutational signatures in patients with Hodgkin lymphoma treated with eBEACOPP and their germline DNA, raising concerns for the genomic health of survivors of Hodgkin lymphoma and hereditary consequences for their offspring. However, replacing procarbazine with dacarbazine appears to mitigate gonadal and stem-cell toxicity while maintaining similar clinical efficacy.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet-
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study - The Lancet Oncology https://t.co/IfVRAOPom1
-
-
Mashup Score: 1Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus - OncoDaily - 9 day(s) ago
Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus / Annals of Oncology, cancer, drug development, OncoDaily, Oncology, Precision
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Optimizing Tomorrow’s Drug Development with Project Optimus - @VivekSubbiah https://t.co/FfAtXDYrKA #Cancer #DrugDevelopm…
-
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now | JCO Oncology Practice https://t.co/pITQpPQRs9